News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
09 06 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare...
09 06 2017 New examination of 3.4 million drug monitoring lab results shows wide evidence of dangerous drug combinations, including opioids/benzodiazepines and heroin/fentanylA majority of test results of patients taking prescription medications show signs of drug misuse, including potentially dangerous drug combinations, finds a new large-scale analysis of laboratory...
-
08 18 2017 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share,...
-
07 25 2017 - Second quarter revenues of $1.94 billion, up 1.9% on a reported basis and up 2.3% on an equivalent basis versus 2016.Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2017 and raised...
07 19 2017 QHerit Expanded Carrier Screen helps both women and men across multiple ethnicities identify risk of passing 22 genetic diseases to their childrenQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of QHerit™, a new genetic screening service that provides women and men...
-
07 18 2017 Quest Diagnostics (NYSE: DGX) today announced that it has completed its previously announced acquisition of the laboratory businesses Med Fusion and Clear Point. Operating from a nearly 200,000...
-
07 06 2017 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2017 results on Tuesday, July 25, 2017,...
-
06 27 2017 Acquisition to Enhance Access to Innovative, High-value Diagnostic Information Services for People on Cape CodQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has signed a nonbinding letter of intent to acquire the outreach laboratory...
-
06 26 2017 MADISON, N.J. and BENTONVILLE, Ark., June 26, 2017-- Quest Diagnostics (NYSE: DGX) and Wal-Mart Stores, Inc. (NYSE: WMT), announced they will be working together to help improve access to care...
06 22 2017 Quest Diagnostics Adds Custom Coaching, At-Home Collection to Expand Blueprint for Athletes™ ServiceFitness enthusiasts can customize biometric testing service to fit their lifestyle with redesigned packages, one-on-one coaching and goal setting as well as at-home phlebotomy and microsamplingFitness devotees and amateur and competitive athletes can now access sports biomarker testing from their home with a suite of expanded capabilities from Blueprint for Athletes, the biomarker...